Urinary catheter | Peripheral intravenous catheter | Central intravenous catheter |
---|---|---|
Acute urinary retention or bladder outlet obstruction (≥150 cc) | Delivery of peripherally compatible infusate (IV fluids and medications), at least once in 24 h | Delivery of non-peripherally compatible infusate (e.g., irritants or vesicants), regardless of proposed duration of use |
Accurate measurements of urinary output in critically ill patients required for treatment | Transfusion of blood and blood products | PICC : delivery of peripherally compatible infusate, with a duration of use which will likely confine ≥ 6 daysb |
Volume measurements of urine output aim for diagnostics (24 h urine), which cannot be assessed by other collection strategies | Injection of contrast fluids | Invasive hemodynamic monitoring or requirement to obtain central venous access in critically ill patients -Nontunneled CVC : duration of use will likely confine < 15 days -PICC : duration of use will likely confine ≥ 15 days |
Assist in healing of open sacral or perineal wounds in patients with urinary incontinence | Intravenous access for cardiac dysrhythmia | PICC : Delivery of cyclical or episodic chemotherapy that can be administered through a peripheral vein, provided that the proposed duration of such treatment is ≥3 months |
Continuous bladder irrigation for hematuria | PIVC : duration of use will likely confine ≤ 5 days | Frequent phlebotomy (every 8 h), provided that the proposed duration of such use is ≥6 days |
Patient requires prolonged immobilization | Midline : duration of use will likely confine ≤ 14 daysa | PICC : Intermittent infusions or infrequent phlebotomy in patients with poor/difficult peripheral venous access, provided that the proposed duration of such use is ≥ 6 days |
Palliative care for terminally ill if needed | Â | PICC: For infusions or palliative treatment during end-of-life care |
Pre- or postoperative according (local) protocol |  | Tunneled catheter or port : preferred if proposed duration is ≥ 31 day |